PRE 14A

PRELIMINARY PROXY STATEMENT

Company: Unicycive Therapeutics, Inc.
Filed: April 18, 2023
Period of Report: April 18, 2023
Accession Number: 0001213900-23-030746

View Document ↗ View on SEC.gov ↗